Purpose of this Study
If you choose to join this study, you will:
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test
- Give a saliva sample
- Have a genetic test using the Color Genomics 30 gene hereditary panel test
Who Can Participate?
Eligibility
Women diagnosed with high-risk breast lesions including:
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)
- Lobular carcinoma in situ (LCIS)
- Atypical ductal hyperplasia (ADH)
- Atypical lobular hyperplasia (ALH)
- Flat epithelial atypia (FEA)
- Columnar cell hyperplasia (CCH)
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
We are doing this study to screen women diagnosed with high-risk breast lesions for genetic mutations that may be linked to a future risk of cancer.
Locations
Remote/online
Compensation
No
Spanish Materials Available
No
Study Details
Full Title
Genetic testing for women with high-risk breast lesions
Principal Investigator
Jennifer
Plichta
Protocol Number
PRO00089223
NCT ID
NCT00000000
Phase
N/A
Enrollment Status
OPEN TO ACCRUAL